|
1
|
Giroux Leprieur E, Dumenil C, Julie C,
Giraud V, Dumoulin J, Labrune S and Chinet T: Immunotherapy
revolutionises non-small-cell lung cancer therapy: Results,
perspectives and new challenges. Eur J Cancer. 78:16–23. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Garrison GW: Lung cancer screening. Cancer
Cytopathol. 124:533–534. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Remon J, Besse B and Soria JC: Successes
and failures: What did we learn from recent first-line treatment
immunotherapy trials in non-small cell lung cancer? BMC Med.
15:552017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Masters GA, Temin S, Azzoli CG, Giaccone
G, Baker S Jr, Brahmer JR, Ellis PM, Gajra A, Rackear N, Schiller
JH, et al: Systemic therapy for stage IV non-small-cell lung
cancer: American society of clinical oncology clinical practice
guideline update. J Clin Oncol. 33:3488–3515. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bjørnetrø T, Handeland KR, Meltzer S,
Samiappan R, Lyckander LG, Jegerschöld C, Sønstevold L, Thusyanthan
NS, Redalen KR and Ree AH: Low release of exosomal miR-663a from
hypoxic tumor cells and poor tumor response to neoadjuvant
radiotherapy in rectal cancer patients. Cancer Res.
77:45142017.
|
|
8
|
Horsman MR and Overgaard J: The impact of
hypoxia and its modification of the outcome of radiotherapy. J
Radiat Res. 57(Suppl 1): i90–i98. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Song G, Ji C, Liang C, Song X, Yi X, Dong
Z, Yang K and Liu Z: TaOx decorated perfluorocarbon nanodroplets as
oxygen reservoirs to overcome tumor hypoxia and enhance cancer
radiotherapy. Biomaterials. 112:257–263. 2017. View Article : Google Scholar
|
|
10
|
Bonnet M, Hong CR, Wong WW, Liew LP, Shome
A, Wang J, Gu Y, Stevenson RJ, Qi W, Anderson RF, et al:
Next-generation hypoxic cell radiosensitizers: Nitroimidazole
alkylsulfonamides. J Med Chem. 61:1241–1254. 2018. View Article : Google Scholar
|
|
11
|
Xiao HT, Wen B, Ning ZW, Zhai LX, Liao CH,
Lin CY, Mu HX and Bian ZX: Cyclocarya paliurus tea leaves enhances
pancreatic β cell preservation through inhibition of apoptosis. Sci
Rep. 7:91552017. View Article : Google Scholar
|
|
12
|
Xie JH, Xie MY, Nie SP, Shen MY, Wang YX
and Li C: Isolation, chemical composition and antioxidant
activities of a water-soluble polysaccharide from Cyclocarya
paliurus (Batal.) Iljinskaja. Food Chem. 119:1626–1632. 2010.
View Article : Google Scholar
|
|
13
|
Xie JH, Liu X, Shen MY, Nie SP, Zhang H,
Li C, Gong DM and Xie MY: Purification, physicochemical
characterisation and anticancer activity of a polysaccharide from
Cyclocarya paliurus leaves. Food Chem. 136:1453–1460. 2013.
View Article : Google Scholar
|
|
14
|
Li S, Li J, Guan XL, Li J, Deng SP, Li LQ,
Tang MT, Huang JG, Chen ZZ and Yang RY: Hypoglycemic effects and
constituents of the barks of Cyclocarya paliurus and their
inhibiting activities to glucosidase and glycogen phosphorylase.
Fitoterapia. 82:1081–1085. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu CX and Cheng BQ: Radiosensitizing
effects of Lycium barbarum polysaccharide for Lewis lung cancer.
Zhong Xi Yi Jie He Za Zhi. 11:611–612. 5821991.In Chinese.
|
|
16
|
Meng X, Grötsch B, Luo Y, Knaup KX,
Wiesener MS, Chen XX, Jantsch J, Fillatreau S, Schett G and Bozec
A: Hypoxia-inducible factor-1α is a critical transcription factor
for IL-10-producing B cells in autoimmune disease. Nat Commun.
9:2512018. View Article : Google Scholar
|
|
17
|
Szalowska E, Stoopen G, Rijk JC, Wang S,
Hendriksen PJ, Groot MJ, Ossenkoppele J and Peijnenburg AA: Effect
of oxygen concentration and selected protocol factors on viability
and gene expression of mouse liver slices. Toxicol In Vitro.
27:1513–1524. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zou K, Tong E, Xu Y, Deng X and Zou L:
Down regulation of mammalian target of rapamycin decreases HIF-1α
and survivin expression in anoxic lung adenocarcinoma A549 cell to
elemene and/or irradiation. Tumour Biol. 35:9735–9741. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Peery RC, Liu JY and Zhang JT: Targeting
survivin for therapeutic discovery: Past, present, and future
promises. Drug Discov Today. 22:1466–1477. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nakahara T, Morita A, Yagasaki R, Mori A
and Sakamoto K: Mammalian target of rapamycin (mTOR) as a potential
therapeutic target in pathological ocular angiogenesis. Biol Pharm
Bull. 40:2045–2049. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bahrami A, Hasanzadeh M, Hassanian SM,
ShahidSales S, Ghayour-Mobarhan M, Ferns GA and Avan A: The
potential value of the PI3K/Akt/mTOR signaling pathway for
assessing prognosis in cervical cancer and as a target for therapy.
J Cell Biochem. 118:4163–4169. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cao ZX, Yang YT, Yu S, Li YZ, Wang WW,
Huang J, Xie XF, Xiong L, Lei S and Peng C: Pogostone induces
autophagy and apoptosis involving PI3K/Akt/mTOR axis in human
colorectal carcinoma HCT116 cells. J Ethnopharmacol. 202:20–27.
2017. View Article : Google Scholar
|
|
23
|
Oh TI, Lee YM, Nam TJ, Ko YS, Mah S, Kim
J, Kim Y, Reddy RH, Kim YJ, Hong S and Lim JH: Fascaplysin exerts
anti-cancer effects through the downregulation of survivin and
HIF-1α and inhibition of VEGFR2 and TRKA. Int J Mol Sci. 18:pii:
E20742017. View Article : Google Scholar
|
|
24
|
Wang Z, Xie J, Yang Y, Zhang F, Wang S, Wu
T, Shen M and Xie M: Sulfated Cyclocarya paliurus polysaccharides
markedly attenuates inflammation and oxidative damage in
lipopolysaccharide-treated macrophage cells and mice. Sci Rep.
7:404022017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cheki M, Shirazi A, Mahmoudzadeh A, Bazzaz
JT and Hosseinimehr SJ: The radioprotective effect of metformin
against cytotoxicity and genotoxicity induced by ionizing radiation
in cultured human blood lymphocytes. Mutat Res. 809:24–32. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
27
|
Her S, Jaffray DA and Allen C: Gold
nanoparticles for applications in cancer radiotherapy: Mechanisms
and recent advancements. Adv Drug Deliv Rev. 109:84–101. 2017.
View Article : Google Scholar
|
|
28
|
Weichselbaum RR, Liang H, Deng L and Fu
YX: Radiotherapy and immunotherapy: A beneficial liaison? Nat Rev
Clin Oncol. 14:365–379. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Garcia-Aranda M, Téllez T, Muñoz M and
Redondo M: Clusterin inhibition mediates sensitivity to
chemotherapy and radiotherapy in human cancer. Anticancer Drugs.
28:702–716. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Guo Y, Sun W, Gong T, Chai Y, Wang J, Hui
B, Li Y, Song L and Gao Y: miR-30a radiosensitizes non-small cell
lung cancer by targeting ATF1 that is involved in the
phosphorylation of ATM. Oncol Rep. 37:1980–1988. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang J, Wang Y, Mei H, Yin Z, Geng Y,
Zhang T, Wu G and Lin Z: The BET bromodomain inhibitor JQ1
radiosensitizes non-small cell lung cancer cells by upregulating
p21. Cancer Lett. 391:141–151. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang H, Mu X, He H and Zhang XD: Cancer
radiosensitizers. Trends Pharmacol Sci. 39:24–48. 2018. View Article : Google Scholar
|
|
33
|
Xu H, Sun G, Wang H, Yue Q, Tang H and Wu
Q: Dynamic observation of the radiosensitive effect of irisquinone
on rabbit VX2 lung transplant tumors by using
fluorine-18-deoxyglucose positron emission tomography/computed
tomography. Nucl Med Commun. 34:220–228. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Brown JM and Le QT: Tumor hypoxia is
important in radiotherapy, but how should we measure it? Int J
Radiat Oncol Biol Phys. 54:1299–1301. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Toffoli S and Michiels C: Intermittent
hypoxia is a key regulator of cancer cell and endothelial cell
interplay in tumours. FEBS J. 275:2991–3002. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bruick RK and Mcknight SL: A conserved
family of prolyl-4-hydroxylases that modify HIF. Science.
294:1337–1340. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Berra E, Roux D, Richard DE and Pouysségur
J: Hypoxia-inducible factor-1 alpha (HIF-1 alpha) escapes
O(2)-driven proteasomal degradation irrespective of its subcellular
localization: Nucleus or cytoplasm. EMBO Rep. 2:615–620. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jaakkola P, Mole DR, Tian YM, Wilson MI,
Gielbert J, Gaskell SJ, von Kriegsheim A, Hebestreit HF, Mukherji
M, Schofield CJ, et al: Targeting of HIF-alpha to the von
Hippel-Lindau ubiquitylation complex by O2-regulated
prolyl hydroxylation. Science. 292:468–472. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wouters BG and Koritzinsky M: Hypoxia
signalling through mTOR and the unfolded protein response in
cancer. Nat Rev Cancer. 8:851–864. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rödel F, Hoffmann J, Distel L, Herrmann M,
Noisternig T, Papadopoulos T, Sauer R and Rödel C: Survivin as a
radioresistance factor, and prognostic and therapeutic target for
radiotherapy in rectal cancer. Cancer Res. 65:4881–4887. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Han C, Nie SP, Huang DF, Chen YQ, Xie JH
and Xie MY: Effects of polysaccharides from Cyclocarya paliurus
(Batal.) Iljinskjk on growth of MGC803 Cells. Nat Prod Res Dev.
21:952–955. 2009.
|
|
42
|
Xie JH, Wang ZJ, Shen MY, Nie SP, Gong B,
Li HS, Zhao Q, Li WJ and Yang G: Sulfated modification,
characterization and antioxidant activities of polysaccharide from
Cyclocarya paliurus. Food Hydrocoll. 53:7–15. 2016. View Article : Google Scholar
|
